Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 April 2022 | Story Jóhann Thormählen
Shimlas
Jooste Nel was one of the Shimla stars in 2022. The centre was chosen as the Player That Rocks against the Madibaz this week. Photo: ASEM Engage, Ian Fairley

It was their aim to entertain, and now the University of the Free State (UFS) Shimlas want to continue in the same vein in front of their home fans in the Varsity Cup semi-final that will be played on Shimla Park on the Bloemfontein Campus on Monday 18 April 2022 at 19:00.

According to Thabang Mahlasi, the Shimla captain, his side is excited to have a home advantage against the University of Pretoria (UP) Tuks and would like to reward their supporters by scoring more tries.

The Shimlas also got their faithful involved this week by launching an ‘Every Fellow’ campaign on social media to encourage supporters to stand together and sing the Shimla song.

One of the Shimlas’ biggest fans, Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, says he will cheer on the team, wishing for another Varsity Cup trophy if the UFS reaches the final. “The UFS is home to top sports stars and winning the Varsity Rugby Cup – following our triumph in the Varsity Netball competition – will be great. Good luck to the team and know that every fellow Kovsie is behind you.”  

Big turnaround
The UFS defeated the Nelson Mandela University 72-24 in Gqeberha in its last league match this week to end first on the log. It was the fourth time in 2022 that the Shimlas scored 50 points or more.

This means they will host UP Tuks, who finished fourth, at Shimla Park on Monday, while the University of Cape Town and Stellenbosch University will play in Cape Town in the other semi-final.

The UFS play against the defending champions in the semi-final in what will be a tight affair. In a previous encounter with UP Tuks this month, Shimlas won 26-15.

It was quite a turnaround for the Shimlas, who finished seventh last year. It will be the first time since 2019 that they play in a semi-final.

“What a big confidence booster to play in front of our own supporters,” says Mahlasi.

“Apart from that, we don’t have to travel, which means our bodies will be fresh come Monday.”

He thanked the fans for their continued support and says, “they will be in for quite a show on Monday”.

Sign of unity
The Shimlas got their supporters behind them with a campaign on their Instagram page (@shimlasrugby). Fans can win money if they sing the Shimla song, ‘Every Fellow’, in a video, or use the audio with their favourite Shimla memory.

Mahlasi says the idea is to get fans to sing the song to motivate the team while playing.

“And also, after the game it would be nice if we could all stand and sing together. As a sign of unity.”

“Our main focus is scoring tries,” says Mahlasi.

“For us, it’s not about the semi-final. For us, it’s just another opportunity to score as many tries as we can.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept